Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
03 2022
Historique:
received: 19 06 2020
revised: 20 10 2020
accepted: 24 10 2020
pubmed: 2 11 2020
medline: 17 3 2022
entrez: 1 11 2020
Statut: ppublish

Résumé

Constipation can be an important symptom in some patients with gastroparesis. The aims were to: 1) Determine prevalence of constipation and delayed colonic transit in patients with symptoms of gastroparesis; 2) Correlate severity of constipation to severity of symptoms of gastroparesis; and 3) Relate severity of constipation to GI transit delays assessed by gastric emptying scintigraphy (GES) and wireless motility capsule (WMC). Patients with symptoms of gastroparesis underwent gastric emptying scintigraphy (GES), wireless motility capsule (WMC) assessing gastric emptying, small bowel transit, and colonic transit, and questionnaires assessing symptoms using a modified Patient Assessment of Upper GI Symptoms [PAGI-SYM] and Rome III functional GI disorder questionnaire. Of 338 patients with symptoms of gastroparesis, 242 (71.5%) had delayed gastric emptying by scintigraphy; 298 (88.2%) also met criteria for functional dyspepsia. Severity of constipation was severe/very severe in 34% patients, moderate in 24%, and none/very mild/mild in 42%. Increasing severity of constipation was associated with increasing symptoms of gastroparesis and presence of irritable bowel syndrome (IBS). Severity of constipation was not associated with gastric retention on GES or WMC. Delayed colonic transit was present in 108 patients (32% of patients). Increasing severity of constipation was associated with increasing small bowel transit time, colonic transit time, and whole gut transit time. Severe/very severe constipation and delayed colon transit occurs in a third of patients with symptoms of gastroparesis. The severity of constipation is associated with severity of gastroparesis symptoms, presence of IBS, small bowel and colon transit delay, but not delay in gastric emptying. ClinicalTrials.gov Identifier: NCT01696747.

Sections du résumé

BACKGROUND & AIMS
Constipation can be an important symptom in some patients with gastroparesis. The aims were to: 1) Determine prevalence of constipation and delayed colonic transit in patients with symptoms of gastroparesis; 2) Correlate severity of constipation to severity of symptoms of gastroparesis; and 3) Relate severity of constipation to GI transit delays assessed by gastric emptying scintigraphy (GES) and wireless motility capsule (WMC).
METHODS
Patients with symptoms of gastroparesis underwent gastric emptying scintigraphy (GES), wireless motility capsule (WMC) assessing gastric emptying, small bowel transit, and colonic transit, and questionnaires assessing symptoms using a modified Patient Assessment of Upper GI Symptoms [PAGI-SYM] and Rome III functional GI disorder questionnaire.
RESULTS
Of 338 patients with symptoms of gastroparesis, 242 (71.5%) had delayed gastric emptying by scintigraphy; 298 (88.2%) also met criteria for functional dyspepsia. Severity of constipation was severe/very severe in 34% patients, moderate in 24%, and none/very mild/mild in 42%. Increasing severity of constipation was associated with increasing symptoms of gastroparesis and presence of irritable bowel syndrome (IBS). Severity of constipation was not associated with gastric retention on GES or WMC. Delayed colonic transit was present in 108 patients (32% of patients). Increasing severity of constipation was associated with increasing small bowel transit time, colonic transit time, and whole gut transit time.
CONCLUSIONS
Severe/very severe constipation and delayed colon transit occurs in a third of patients with symptoms of gastroparesis. The severity of constipation is associated with severity of gastroparesis symptoms, presence of IBS, small bowel and colon transit delay, but not delay in gastric emptying. ClinicalTrials.gov Identifier: NCT01696747.

Identifiants

pubmed: 33130007
pii: S1542-3565(20)31503-2
doi: 10.1016/j.cgh.2020.10.045
pmc: PMC8079462
mid: NIHMS1643806
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01696747']

Types de publication

Clinical Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

546-558.e5

Subventions

Organisme : NIDDK NIH HHS
ID : U24 DK074008
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK074008
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK112194
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK074007
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK073975
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK074035
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK073974
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK073983
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK112193
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 AGA Institute. All rights reserved.

Références

J Neurogastroenterol Motil. 2019 Apr 30;25(2):267-275
pubmed: 30870880
Clin Gastroenterol Hepatol. 2011 Jul;9(7):567-76.e1-4
pubmed: 21397732
Neurogastroenterol Motil. 2014 Jan;26(1):131-8
pubmed: 24118658
Aliment Pharmacol Ther. 2003 Jul 1;18(1):141-50
pubmed: 12848636
Am J Gastroenterol. 2000 Oct;95(10):2838-47
pubmed: 11051357
Aliment Pharmacol Ther. 2017 Dec;46(11-12):1103-1111
pubmed: 28983926
Aliment Pharmacol Ther. 2010 Jan 15;31(2):313-22
pubmed: 19814743
Gastroenterology. 2004 Nov;127(5):1592-622
pubmed: 15521026
J Clin Gastroenterol. 2011 Sep;45(8):684-90
pubmed: 21135705
Am J Gastroenterol. 2000 Jun;95(6):1456-62
pubmed: 10894578
Adv Ther. 2017 Dec;34(12):2680-2692
pubmed: 29079987
Am J Gastroenterol. 2019 Aug;114(8):1265-1274
pubmed: 31295161
Gastroenterology. 1993 Sep;105(3):781-90
pubmed: 8359649
Clin Gastroenterol Hepatol. 2010 May;8(5):401-9
pubmed: 19631762
Neurogastroenterol Motil. 2018 Feb;30(2):
pubmed: 28872760
Expert Rev Clin Pharmacol. 2019 Jul;12(7):579-589
pubmed: 31096799
Am J Gastroenterol. 2008 Mar;103(3):753-63
pubmed: 18028513
Am J Gastroenterol. 2004 Jun;99(6):1152-9
pubmed: 15180740
Scand J Gastroenterol. 2003 Jan;38(1):36-42
pubmed: 12608462
Dig Dis Sci. 1993 May;38(5):832-6
pubmed: 8482181
Qual Life Res. 2004 Dec;13(10):1737-49
pubmed: 15651544

Auteurs

Henry P Parkman (HP)

Temple University, Philadelphia, Pennsylvania. Electronic address: henry.parkman@temple.edu.

Emily Sharkey (E)

Johns Hopkins University, Baltimore, Maryland.

Richard W McCallum (RW)

Texas Tech University, El Paso, Texas.

William L Hasler (WL)

University of Michigan, Ann Arbor, Michigan.

Kenneth L Koch (KL)

Wake Forest University, Winston-Salem, North Carolina.

Irene Sarosiek (I)

Texas Tech University, El Paso, Texas.

Thomas L Abell (TL)

University of Louisville, Louisville, Kentucky.

Braden Kuo (B)

Harvard Medical School, Boston, Massachusetts.

Robert J Shulman (RJ)

Baylor College of Medicine, Houston, Texas.

Madhusudan Grover (M)

Mayo Clinic, Rochester, Minnesota.

Gianrico Farrugia (G)

Mayo Clinic, Rochester, Minnesota.

Ron Schey (R)

Temple University, Philadelphia, Pennsylvania.

James Tonascia (J)

Johns Hopkins University, Baltimore, Maryland.

Frank Hamilton (F)

National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.

Pankaj J Pasricha (PJ)

Johns Hopkins University, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH